Table 1 Composition of the ASPN Therapeutics Development Committee

From: Enhancing clinical trial development for pediatric kidney diseases

Participant representation Number of members
Pediatric nephrologists Seven, including two ASPN officers ex-officio
Industry Six different firms represented
NIDDK One member
NICHD One member
FDA Three members, two of whom are pediatric nephrologists; one each in Center for Drug Evaluation of Research (CDER), Division of Cardiovascular and Renal Products; CDER, Division of Pediatrics and Maternal Health; and Center for Devices and Radiological Health.
PCORI One member
Patient advocacy groups Two foundations
  1. ASPN, American Society of Pediatric Nephrology.